ArticleNature communications2025
Antibacterial microcins are ubiquitous and functionally diverse across bacterial communities.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Review
- Bacterial weaponry and the ecological factors of competitive success.Essays in biochemistry · 2026Review
- Postbiotics Against Breast Cancer: A Narrative Review Bridging Preclinical Evidence with Potential Clinical Application.Cancers · 2026Review
- Analysis of a collection of Escherichia coli isolates recovered from beach waters on the coast of the Río de la Plata in Montevideo.Antonie van Leeuwenhoek · 2026Article
- Prevalence and activity of class II microcins inApplied and environmental microbiology · 2026Article
- Refactored genetic parts for modular assembly of the E. coli MccV type I secretion system used to screen class II microcin candidates from plant-associated bacteria.BMC biotechnology · 2026Article
- Antibacterial microcins self-assemble to promote biofilm formation in Acinetobacter baumannii.Cell reports · 2026Article
- Antibacterial microcins are ubiquitous and functionally diverse across bacterial communities.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Bacteria produce antibacterials that drive competition and regulate community composition. While diverse examples have been found, few families of antibacterial agents appear to be widespread across phylogenetically divergent bacteria. Here, we show that what appeared to be a limited, niche class of Gram-negative bacteriocins, called class II microcins, is in fact a highly abundant, sequence- and function-diverse class of secreted bacteriocins. Based on systematic investigations in the Enterobacteriaceae and gut microbiomes, we demonstrate that class II microcins encompass diverse sequence space, bacterial strains of origin, spectra of activity, and mechanisms of action. Importantly, we show microcins discovered here are active against pathogenic E. coli during mouse gut colonization, supporting important roles for these unrecognized antibacterials in vivo. Our study reveals the overlooked abundance and diversity of microcins found dispersed throughout Bacteria and opens opportunities to uncover and exploit mechanisms of competition to modulate microbial communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.